An investigation on behalf of investors of MultiPlan Corporation (NYSE: MPLN) shares over potential securities laws violations by MultiPlan Corporation and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of MultiPlan Corporation (NYSE: MPLN) concerning whether a series of statements by MultiPlan Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

New York based MultiPlan Corporation provides data analytics and technology-enabled cost management solutions to the U.S. healthcare industry.

On November 11, 2020, a report was published entitled MultiPlan: Private Equity Necrophilia Meets The Great 2020 Money Grab[.] The report described a series of issues involving MultiPlan Corporation including that MPLN is in the process of losing its largest client, UnitedHealthcare (UHC). UHC has formed a competitor to MPLN that offers significantly lower prices and fewer conflicts of interest.

Shares of MultiPlan Corporation (NYSE: MPLN) declined from $9.14 per share on November 6, 2020 to as low as $6.12 per share on November 12, 2020.